Richard A. Erali - Concepedia

Author

Richard A. Erali

Atrium Health Wake Forest Baptist ORCID

Also Known As

R. Erali, Richard A. Erali, Richard Erali, Richard P. Erali

Publications

700

Citations

H-Index

Concepts

All Affiliations

Atrium Health Wake Forest Baptist Wake Forest University Mayo Clinic in Florida Forest Institute Jacksonville College

About

Richard A. Erali is an author at Atrium Health Wake Forest Baptist specializing in medicine, surgical oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	106
2	Surgical Oncology	3	3	83
3	Public Health	1	1	23
4	Endocrinology	1	1	23
5	Metabolism	1	1	23

Richard A. Erali

Publications

611

Citations

H-Index

Page 1

	Year	Citations
Epidemiology of Pediatric Fractures Presenting to Emergency Departments in the United States Sameer Naranje, Richard A. Erali, William C. Warner, Journal of Pediatric Orthopaedics	2015	389
Organoid Platform in Preclinical Investigation of Personalized Immunotherapy Efficacy in Appendiceal Cancer: Feasibility Study Steven D. Forsythe, Richard A. Erali, Shyama Sasikumar, Clinical Cancer Research	2021	68
Patient-Specific Sarcoma Organoids for Personalized Translational Research: Unification of the Operating Room with Rare Cancer Research and Clinical Implications Steven D. Forsythe, Hemamylammal Sivakumar, Richard A. Erali, Annals of Surgical Oncology Translational MedicineSurgical OncologyOperating RoomClinical TranslationMedicine	2022	57
Thyroid Function Tests in Domesticated Animals: Free Thyroxine Index Francis A. Kallfelz, Richard A. Erali American Journal of Veterinary Research CaprineIodine Deficiency DisordersClinical ChemistryPublic HealthThyroid Physiology	1973	23
Application of immune enhanced organoids in modeling personalized Merkel cell carcinoma research Steven D. Forsythe, Richard A. Erali, Preston Laney, Scientific Reports	2022	20
Surgical drain placement in distal pancreatectomy is associated with an increased incidence of postoperative pancreatic fistula and higher readmission rates Christopher W. Mangieri, Michael Kuncewitch, Brett Fowler, Journal of Surgical Oncology	2020	15
Long-Term Survival in Patients Treated with Cytoreduction and Heated Intraperitoneal Chemotherapy for Peritoneal Mesothelioma at a Single High-Volume Center Cristian D. Valenzuela, Ian Solsky, Richard A. Erali, Annals of Surgical Oncology Surgical OncologyMedicineMetronomic TherapyLong-term SurvivalSingle High-volume Center	2023	15
Utility of hyperthermic intraperitoneal chemotherapy in cases of incomplete cytoreductive surgery Christopher W. Mangieri, Omeed Moaven, Cristian D. Valenzuela, Journal of Surgical Oncology	2021	13
Utility of Neoadjuvant Chemotherapy for Peritoneal Carcinomatosis Secondary to High-Grade Appendiceal Neoplasms for Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Christopher W. Mangieri, Omeed Moaven, Cristian D. Valenzuela, Annals of Surgical Oncology High-grade Appendiceal NeoplasmsSurgical OncologyGastrointestinal OncologyMedicineMetronomic Therapy	2022	11

Page 1